Tutorials
NAS:ABCL (Canada)  
AbCellera Biologics Inc logo

AbCellera Biologics Inc

$ 11.11 -0.65 (-5.53%) 04:00 PM EST
P/E:
17.26
P/B:
2.62
Market Cap:
$ 3.15B
Enterprise V:
$ 2.60B
Volume:
2.69M
Avg Vol (2M):
2.94M
Also Trade In:
Volume:
2.69M
Market Cap $:
3.15B
PE Ratio:
17.26
Avg Vol (2-Month):
2.94M
Enterprise Value $:
2.60B
PB Ratio:
2.62
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

AbCellera Biologics Inc
NAICS : 541714 SIC : 3741
2215 Yukon Street, Vancouver, BC, CAN, V5Y 0A1
Description
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Name Current Vs Industry Vs History
Cash-To-Debt 19.52
Equity-to-Asset 0.76
Debt-to-Equity 0.03
Debt-to-EBITDA 0.13
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.23
Distress
Grey
Safe
Beneish M-Score -2.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 84.89
9-Day RSI 73.48
14-Day RSI 67.71
6-1 Month Momentum % 25.32
12-1 Month Momentum % -22.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.5
Quick Ratio 5.5
Cash Ratio 3.68
Days Inventory 7.11
Days Sales Outstanding 84.3
Days Payable 45.14

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6

Financials (Next Earnings Date:2022-08-09)

ABCL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ABCL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 489.063
EPS (TTM) ($) 0.642
Beta 0
Volatility % 70.65
14-Day RSI 67.71
14-Day ATR ($) 0.599381
20-Day SMA ($) 10.70825
12-1 Month Momentum % -22.65
52-Week Range ($) 5.42 - 22.6337
Shares Outstanding (Mil) 284.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AbCellera Biologics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More